{"id":223457,"date":"2026-08-31T10:36:12","date_gmt":"2026-08-31T05:06:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=223457"},"modified":"2026-08-31T10:36:12","modified_gmt":"2026-08-31T05:06:12","slug":"why-piramal-pharma-share-price-price-fall-2026-08-31","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/","title":{"rendered":"Piramal Pharma (PPLPHARMA) Share Price Falls 2.95% to Rs 212.15 Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/pplpharma\/piramal-pharma-ltd-share-price-today\">Piramal Pharma (PPLPHARMA)<\/a> share price fell to Rs 212.15 today, down 2.95% from the previous close. Market cap was Rs 29,103.27 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;31 August 2026 at 9:50:21 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Piramal Pharma Share Price was Rs 212.15 today, down 2.95% from the previous close, while market capitalisation stood at Rs 29,103.27 crore. Piramal Pharma is in the Large Cap category, and today\u2019s decline is the main stock news event. The supplied data confirms the price event and shows where the stock closed in the session, but it does not establish a company-specific catalyst. For readers tracking Piramal Pharma Share Price Today, the move matters because it follows a close of Rs 218.6 and leaves the stock near the day\u2019s low of Rs 212.15. Univest is covering the move with a price-action lens, valuation context and peer comparison so investors can place the decline in a broader market frame.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#Piramal_Pharma_PPLPHARMA_Share_Price_Today_Price_Action_Analysis\" title=\"Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis\">Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#Piramal_Pharma_PPLPHARMA_Fundamental_Analysis\" title=\"Piramal Pharma (PPLPHARMA) Fundamental Analysis\">Piramal Pharma (PPLPHARMA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#Why_Investors_Are_Watching_Piramal_Pharma\" title=\"Why Investors Are Watching Piramal Pharma\">Why Investors Are Watching Piramal Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#About_Piramal_Pharma\" title=\"About Piramal Pharma\">About Piramal Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#Track_Piramal_Pharma_Share_Price_on_Univest\" title=\"Track Piramal Pharma Share Price on Univest\">Track Piramal Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#Why_is_Piramal_Pharma_falling_today\" title=\"Why is Piramal Pharma falling today?\">Why is Piramal Pharma falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#What_is_Piramal_Pharma_Share_Price_today\" title=\"What is Piramal Pharma Share Price today?\">What is Piramal Pharma Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#What_does_Piramal_Pharma_Share_Price_news_show_for_the_session\" title=\"What does Piramal Pharma Share Price news show for the session?\">What does Piramal Pharma Share Price news show for the session?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#How_large_is_Piramal_Pharma_in_market-cap_terms\" title=\"How large is Piramal Pharma in market-cap terms?\">How large is Piramal Pharma in market-cap terms?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#What_does_Piramal_Pharma_Fundamental_Analysis_show\" title=\"What does Piramal Pharma Fundamental Analysis show?\">What does Piramal Pharma Fundamental Analysis show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#How_does_Piramal_Pharma_compare_with_healthcare_peers\" title=\"How does Piramal Pharma compare with healthcare peers?\">How does Piramal Pharma compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#What_does_the_sector_benchmark_suggest_for_Piramal_Pharma\" title=\"What does the sector benchmark suggest for Piramal Pharma?\">What does the sector benchmark suggest for Piramal Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-price-fall-2026-08-31\/#Is_Piramal_Pharma_Share_Price_tied_to_positive_earnings_right_now\" title=\"Is Piramal Pharma Share Price tied to positive earnings right now?\">Is Piramal Pharma Share Price tied to positive earnings right now?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_PPLPHARMA_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 212.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 218.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 6.45 (-2.95%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 218.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 218.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 212.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,103.27 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Piramal Pharma Share Price Today reflected a lower session from the open itself. The stock opened at Rs 218.75, exactly at the day\u2019s high, and then eased to a low of Rs 212.15, which was also the closing level. Against the previous close of Rs 218.6, the share price declined by Rs 6.45, or 2.95%, in a single day. Turnover was Rs 1.57 crore, which is the exact traded-value figure supplied for the session.<\/p>\n<p>For a Large Cap company, the day\u2019s price action is notable because the move came without any verified company-specific trigger in the supplied data. That means Piramal Pharma Share Price News today is driven by the recorded market outcome rather than an identified event. The gap between the day high of Rs 218.75 and the close of Rs 212.15 also shows that the stock finished at the bottom of the session\u2019s range. In the context of Piramal Pharma Share Price Fall, investors are left with the facts of the move: lower close, lower net change and a complete retracement from the opening level. The next step in Piramal Pharma Stock News is to look at valuation and company financials for context.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_PPLPHARMA_Fundamental_Analysis\"><\/span><strong>Piramal Pharma (PPLPHARMA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,103.27 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.64x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-4.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -2.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 60.13<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The profitability and earnings metrics are more restrained. ROE is -4.04, ROCE is 1.24, EPS is -2.36 and book value is Rs 60.13. Dividend yield is 0. These figures indicate that the current Piramal Pharma Share Price is not being supported by positive per-share earnings in the latest supplied data. In an article on Piramal Pharma Share Price Today, EPS and book value are important because they show that the stock is priced well above accounting book value and with negative earnings per share. Univest\u2019s stock analysis also notes that P\/B should be read alongside profitability, not in isolation. The company\u2019s financial profile therefore adds context to the day\u2019s share price fall without implying a cause.<\/p>\n<p>For Piramal Pharma Fundamental Analysis, the key point is not prediction but comparison: the company\u2019s valuation is richer than the industry median on P\/B, while ROE and EPS are both negative and ROCE is low. That combination makes the latest Piramal Pharma Share Price News relevant for investors following company financials and market-cap context.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.7x to 672.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.64x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.19x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-4.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,103.27 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 670.73 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,040.53 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Piramal Pharma operates in Healthcare and the Pharmaceuticals &amp; Drugs industry. The supplied sector snapshot is for the same industry and covers 203 companies, which gives a useful benchmark set for Piramal Pharma Share Price analysis.The industry median P\/E is 31.21, the average P\/E is 48.1, and the range runs from 3.7 to 672.45.<\/p>\n<p>On those measures, Piramal Pharma\u2019s P\/B of 3.64 is above the industry median P\/B of 2.88 but below the industry average P\/B of 4.19. Its ROE of -4.04 is below the industry median ROE of 11.78 and the industry average ROE of 10.68. Its ROCE of 1.24 is also below the industry median ROCE of 13.6 and the industry average ROCE of 13.27. Market capitalisation benchmarks in the same industry show a median of Rs 670.73 crore and an average of Rs 14,040.53 crore, while Piramal Pharma\u2019s own market cap is Rs 29,103.27 crore, which is above both. This sector and industry context helps explain why Piramal Pharma Share Price Today is being watched closely in the healthcare pack even without any new company-specific catalyst in the supplied data.<\/p>\n<p>Univest\u2019s sector analysis indicates that the stock sits within a large industry universe, so the latest Piramal Pharma Share Price Fall should be interpreted against valuation and profitability benchmarks rather than in isolation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,60,696.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,062.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,91,515.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,18,403.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,554.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Piramal Pharma Share Price can also be viewed against listed healthcare peers such as Sun Pharmaceutical Industries, Divi\u2019s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Among these peers, Piramal Pharma\u2019s market cap of Rs 29,103.27 crore is smaller than Sun Pharma, Divi\u2019s, Torrent, Zydus and Cipla, but still substantial in absolute terms.<\/p>\n<p>On valuation, its P\/B of 3.64 is below Sun Pharma\u2019s 5.33, Divi\u2019s 13.93 and Torrent\u2019s 21.34, but above Cipla\u2019s 3.26. Compared with Zydus at 4.39, Piramal Pharma is also lower on P\/B. On profitability, Piramal Pharma\u2019s ROE of -4.04 trails the positive ROE figures of all the listed peers in this set, and its ROCE of 1.24 is also below each of them. In Piramal Pharma Stock Analysis terms, that means the latest Piramal Pharma Share Price News sits in a weaker profitability band than the supplied peer group, even though the company\u2019s market capitalisation is much larger than several benchmark names. Univest highlights that peer comparison is most useful when it stays anchored to exact figures, not assumptions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Piramal_Pharma\"><\/span><strong>Why Investors Are Watching Piramal Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Piramal Pharma Share Price fell 2.95% today to Rs 212.15 from the previous close of Rs 218.6.<\/li>\n<li>The day\u2019s range was Rs 218.75 high and Rs 212.15 low, with the close at the session low.<\/li>\n<li>Market capitalisation stands at Rs 29,103.27 crore and the company is classified as Large Cap.<\/li>\n<li>P\/B is 3.64, while ROE is -4.04, ROCE is 1.24, EPS is -2.36 and book value is Rs 60.13.<\/li>\n<li>In the healthcare industry benchmark, the company\u2019s P\/B is above the median of 2.88 and its profitability metrics are below the benchmark medians.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Piramal_Pharma\"><\/span><strong>About Piramal Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Piramal Pharma belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied data identifies the company in the Large Cap category and places its market capitalisation at Rs 29,103.27 crore. That is the core company overview available for today\u2019s Piramal Pharma Stock News update. Univest uses this factual profile to frame Piramal Pharma Share Price Today within the correct industry and market-cap setting, without adding any unsupported business description. For readers following Piramal Pharma Share Price as part of broader healthcare stock news, the company\u2019s latest price action is best read together with its reported valuation and profitability metrics.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Piramal_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Piramal Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/pplpharma\/piramal-pharma-ltd-share-price-today\">Piramal Pharma (PPLPHARMA) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Investors can track Piramal Pharma Share Price on Univest for live share price updates, valuation ratios, shareholding pattern, 52-week levels and company financials. Univest also brings together Piramal Pharma Stock News, Piramal Pharma Share Price Today and broader market insights in one place for easier monitoring.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Piramal_Pharma_falling_today\"><\/span><strong>Why is Piramal Pharma falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Piramal Pharma Share Price fell 2.95% today to Rs 212.15 from Rs 218.6. The supplied data confirms the price event, but it does not establish a company-specific catalyst for the decline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Piramal_Pharma_Share_Price_today\"><\/span><strong>What is Piramal Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Piramal Pharma Share Price Today is Rs 212.15. The stock closed Rs 6.45 lower than the previous close of Rs 218.6, and the day\u2019s low was also Rs 212.15. The previous close was Rs 218.6.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Piramal_Pharma_Share_Price_news_show_for_the_session\"><\/span><strong>What does Piramal Pharma Share Price news show for the session?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Piramal Pharma Share Price News shows a one-day decline of 2.95%, a session high of Rs 218.75, a session low of Rs 212.15 and turnover of Rs 1.57 crore. The previous close was Rs 218.6.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_large_is_Piramal_Pharma_in_market-cap_terms\"><\/span><strong>How large is Piramal Pharma in market-cap terms?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Piramal Pharma\u2019s market capitalisation is Rs 29,103.27 crore, and the company is classified as Large Cap. That size context is factual and should be read alongside the day\u2019s share price fall.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Piramal_Pharma_Fundamental_Analysis_show\"><\/span><strong>What does Piramal Pharma Fundamental Analysis show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Piramal Pharma Fundamental Analysis shows P\/B of 3.64, ROE of -4.04, ROCE of 1.24, EPS of -2.36, book value of Rs 60.13 and dividend yield of 0. These figures add context to the price action.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Piramal_Pharma_compare_with_healthcare_peers\"><\/span><strong>How does Piramal Pharma compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Compared with peers such as Sun Pharma, Divi\u2019s, Torrent, Zydus and Cipla, Piramal Pharma has a smaller market cap and weaker profitability metrics, while its P\/B is below several peers but above Cipla.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_sector_benchmark_suggest_for_Piramal_Pharma\"><\/span><strong>What does the sector benchmark suggest for Piramal Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;In the same-industry benchmark of 203 companies, Piramal Pharma\u2019s P\/B is above the median, while ROE and ROCE are below the median and average. That gives the stock a mixed sector comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Piramal_Pharma_Share_Price_tied_to_positive_earnings_right_now\"><\/span><strong>Is Piramal Pharma Share Price tied to positive earnings right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The supplied data shows EPS of -2.36, so the current Piramal Pharma Share Price is not supported by positive per-share earnings in this dataset. Book value is Rs 60.13 and dividend yield is 0.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Piramal Pharma Share Price falls to Rs 212.15. marking a 2.95% fall today. Market cap stands at Rs 29,103.27 crore.<\/p>\n","protected":false},"author":29,"featured_media":223456,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-223457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["223456"],"rank_math_title":["Piramal Pharma Share Price Falls 2.95%: Price Action Review"],"rank_math_description":["Piramal Pharma Share Price fell 2.95% to Rs 212.15 today. Read the price action, valuation, sector context and peer comparison."],"rank_math_focus_keyword":["Piramal Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Piramal_Pharma_PPLPHARMA_Share_Price_Falls_295_to_Rs_21215_Today_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/223457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=223457"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/223457\/revisions"}],"predecessor-version":[{"id":223458,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/223457\/revisions\/223458"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/223456"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=223457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=223457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=223457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}